Our Chief Business Officer, Terry Vance, joined a panel at MassBio’s 2018 Annual Meeting that drew over 400 industry leaders. The panel provided insights into family office investments in biotech during the two day event that focused on the most innovative advancements in the biopharma industry.

 

Learn more about the MassBio Annual Meeting here